biotech
Bio-AnalystSupplement research
person

Lemon Balm

Selected research topic

Stress and mood

Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.

Some findings concern patients or people with a deficiency.

Publications for this topic
7
Human comparison publications
1
Publications needing review
5

Findings in the studies

  • anxiety

    • A better result than the comparison group was reported.
      Patient group · Single ingredient · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: Melissa officinalis vs placebo
      Additional measurement information
      Secondary outcome
      Measurement time
      8 weeks
  • depression

    • A better result than the comparison group was reported.
      Patient group · Single ingredient · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: Melissa officinalis vs placebo
      Additional measurement information
      Secondary outcome
      Measurement time
      8 weeks
  • stress

    • A better result than the comparison group was reported.
      Patient group · Single ingredient · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: Melissa officinalis vs placebo
      Additional measurement information
      Secondary outcome
      Measurement time
      8 weeks
  • mood

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient · 1 and 3 hours after treatment
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: within-subject active lemon balm preparations versus placebo across beverage/yoghurt delivery matric
      Measurement time
      1 and 3 hours after treatment

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (3)
  • alpha 1 · Distinct papers needing additional review: 1Direction unclear: 1
  • anxiety score · Distinct papers needing additional review: 1Direction unclear: 1
  • depression score · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Partial research summary

Human studies reported between-group improvement in depression.

These conditions come from related studies and may not describe a single paper.

Single-ingredient studies · Human studies · Includes patient groups · between-group comparison

3 publications linked to this result (2 awaiting review included)

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 33.5 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 58

Papers linked to this topic 7 · distinct papers 7 · papers with a confirmed human comparison 1 · papers needing additional review 5

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • alpha 1: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • anxiety: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • anxiety score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • depression: Sources represented in this measurement group: 3 · Distinct papers with human comparisons for this outcome: 1
  • depression score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • mood: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • stress: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

What the research found

mood

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

anxiety

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

depression

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

stress

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

alpha 1

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

anxiety

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

anxiety score

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

depression

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

depression

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

depression score

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

LD501 papers
Acute oral toxicity of lemon balm essential oil in BALB/c mice showed significant behavioral, biochemical, and pathological changes at doses >1 g kg‑1, with an LD50 of 2.57 g kg‑1.Animal studies · Animal study